Kangmaisi Pharmaceutical

Kangmaisi (Beijing) Pharmaceutical Technology is a China-based biotechnology company and contract research organization (CRO) focused on the research and development of innovative small molecule drugs. The company provides a range of services including medicinal chemistry, pharmaceutical analysis, and process development to support drug discovery efforts. Their internal pipeline primarily targets oncology and metabolic disorders, leveraging their expertise in chemical synthesis and lead optimization. Kangmaisi aims to bridge the gap between early-stage laboratory research and clinical application through high-quality technical services and proprietary drug candidates.